Torthaí cuardaigh - Anuj Kashyap

  • 1 - 4 toradh as 4 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Selective Autophagy of the Adaptor Protein Bcl10 Modulates T Cell Receptor Activation of NF-κB

    Selective Autophagy of the Adaptor Protein Bcl10 Modulates T Cell Receptor Activation of NF-κB de réir Suman Paul, Anuj Kashyap, Wei Jia, You‐Wen He, Brian C. Schaefer

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Novel signal transducer and activator of transcription 1 mutation disrupts small ubiquitin-related modifier conjugation causing gain of function

    Novel signal transducer and activator of transcription 1 mutation disrupts small ubiquitin-related modifier conjugation causing gain of function de réir Elizabeth P. Sampaio, Li Ding, Stacey Rose, Phillip Cruz, Amy P. Hsu, Anuj Kashyap, Lindsey B. Rosen, Margery Smelkinson, Tatyana Almeida Tavella, Elise M. N. Ferré, Meredith K. Wierman, Christa S. Zerbe, Michail S. Lionakis, Steven M. Holland

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Chlamydia evasion of neutrophil host defense results in NLRP3 dependent myeloid-mediated sterile inflammation through the purinergic P2X7 receptor

    Chlamydia evasion of neutrophil host defense results in NLRP3 dependent myeloid-mediated sterile inflammation through the purinergic P2X7 receptor de réir Chunfu Yang, Lei Lei, John W. Marshall Collins, Michael Briones, Li Ma, Gail L. Sturdevant, Hua Su, Anuj Kashyap, David W. Dorward, Kevin W. Bock, Ian N. Moore, Christine Bonner, Chih‐Yu Chen, Craig Martens, Stacy Ricklefs, Masahiro Yamamoto, Kiyoshi Takeda, Yoichiro Iwakura, Grant McClarty, Harlan D. Caldwell

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Effective “activated PI3Kδ syndrome”–targeted therapy with the PI3Kδ inhibitor leniolisib

    Effective “activated PI3Kδ syndrome”–targeted therapy with the PI3Kδ inhibitor leniolisib de réir V. Koneti Rao, Sharon Webster, Virgil A. S. H. Dalm, Anna Šedivá, P. Martin van Hagen, Steven M. Holland, Sergio D. Rosenzweig, Andreas D. Christ, Birgitte Sloth, Maciej Cabanski, Aniket Joshi, Stefan Buck, Julie Doucet, Danilo Guerini, Christoph Kalis, Ilona Pylvaenaeinen, Nicolas Soldermann, Anuj Kashyap, Gülbû Uzel, Michael J. Lenardo, Dhavalkumar D. Patel, C. Lucas, Christoph Burkhart

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: